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Aims Mitochondrial dysfunction is a major factor in heart failure (HF). A pronounced variability of
mitochondrial electron transport chain (ETC) defects is reported to occur in severe acquired cardiomyo-
pathies without a consistent trend for depressed activity or expression. The aim of this study was to
deﬁne the defect in the integrative function of cardiac mitochondria in coronary microembolization-
induced HF.
Methods and results Studies were performed in the canine coronary microembolization-induced HF
model of moderate severity. Oxidative phosphorylation was assessed as the integrative function of mito-
chondria, using a comprehensive variety of substrates in order to investigate mitochondrial membrane
transport, dehydrogenase activity and electron-transport coupled to ATP synthesis. The supramolecular
organization of the mitochondrial ETC also was investigated by native gel electrophoresis. We found a
dramatic decrease in ADP-stimulated respiration that was not relieved by an uncoupler. Moreover, the
ADP/O ratio was normal, indicating no defect in the phosphorylation apparatus. The data point to a
defect in oxidative phosphorylation within the ETC. However, the individual activities of ETC complexes
were normal. The amount of the supercomplex consisting of complex I/complex III dimer/complex IV,
the major form of respirasome considered essential for oxidative phosphorylation, was decreased.
Conclusions We propose that the mitochondrial defect lies in the supermolecular assembly rather than
in the individual components of the ETC.
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1. Introduction
The heart has a continuous requirement for energy in the
form of ATP. Mitochondria are the primary ATP provider via
the conversion of food fuels to usable energy. Compelling
evidence for a link between the decline in mitochondrial
energy transduction and mechanical dysfunction in
heart failure (HF) is found in animal models and in
patients with genetic mitochondrial diseases
1 or acquired
cardiomyopathies.
2–4
Although HF of different aetiology has common cardiac
mechanical dysfunctions, the investigation of mitochondrial
function in humans and animal models of HF shows a variety
of mitochondrial alterations
5 that point to defects at speciﬁc
sites in mitochondrial energy transfer pathways, i.e. the
electron transport chain (ETC)
6 or the phosphorylation
apparatus.
7 However, no comprehensive examination of
cardiac mitochondrial function has been reported in HF.
Studies performed in severe HF show mitochondrial dys-
function, whereas data generated in models with moderate
severity HF are controversial.
5 These conﬂicting data may
beexplainedby differences intheapproachused by different
laboratories to assess mitochondrial function. For example, * Corresponding author. Tel: þ1 216 368 3147; fax: þ1 216 368 5162.
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untillatestages
8inpressureandvolumeoverload-inducedHF.
In contrast, isolated mitochondria from both pressure-
overload
9 and genetic cardiomyopathic hamster hearts
10
exhibited a progressive decline in oxidative phosphorylation
with the severity of HF. Similarly, mitochondrial respiratory
activity was decreased in cardiomyocytes isolated from
humansanddogswithchronicHF,
2,11,12eventhoughthemito-
chondrialvolumedensityandactivityofcitratesynthasewere
normal.
13,14 Defects in mitochondrial function may not be
detected in the early stages of HF when measured in muscle
homogenatesorﬁbresduetopossiblealterationsinmitochon-
drial density
15 and heterogeneity.
16 Moreover, heart mito-
chondria exist as two functionally and biochemically distinct
populations: subsarcolemmal mitochondria (SSM), which are
situated beneath the plasma membrane, and interﬁbrillar
mitochondria (IFM), which are located among the myoﬁ-
brils.
17 Most studies on mitochondrial respiration in HF were
performed on the combined populations of heart mitochon-
driareleasedbypolytronhomogenizationandproteasetreat-
ment.
9,16 The two heart mitochondrial populations may be
affecteddifferentlyinHFbecausetheyarebiochemicallydis-
tinct
17 and they react differently in pathological states such
as aging
18,19 or genetic cardiomyopathy.
10
The goal of the current study was to evaluate the integra-
tive function of SSM and IFM in moderately severe HF.
Studieswereperformedinthewell-establishedcaninecoron-
arymicroembolism-inducedHFmodel.
12,14,20Tothisend,oxi-
dative phosphorylation, as an integrative function of
mitochondria, was assessed with a comprehensive number
of substrates in order to investigate membrane transport,
dehydrogenase activities, and the ETC coupled to ATP syn-
thesis. We found a dramatic decrease in ADP-stimulated res-
piration that was not relieved by an uncoupler. Moreover,
theADP/Oratiowasnormal,indicatingnoeffectonthephos-
phorylationapparatus.Thedatapointtoadefectinoxidative
phosphorylation within the ETC. However, the individual
activity of ETC enzymes was normal. The amount of the
supercomplex consisting of complex I/complex III dimer/
complex IV, the major form of respirasome considered
essential for oxidative phosphorylation, was decreased. In
contrast, the amount of free complexes I and III were
increased in SSM. In summary, there is a dramatic decrease
in oxidative phosphorylation of heart mitochondria isolated
from moderately severe HF, which is associated with a
decrease in the content of ETC respirasome.
2. Methods
Please see the online supplement for additional experimental
details for several of the methods mentioned here.
2.1 Materials, reagents
Unless speciﬁed, all reagents were purchased from Sigma-Aldrich
(St Louis, MO, USA) and were of the highest purity grade.
2.2 Animal model
The investigation conforms with the Guide for the Care and Use of
Laboratory Animals published by the US National Institutes of
Health (NIH Publication No. 85-23, revised 1996). All experimental
protocols were approved by the Henry Ford Hospital and Case
Western Reserve University Institutional Animal Care and Use Com-
mittees. The intracoronary microembolization-induced model was
used to induce HF in dogs, as described.
20,21 A single intracoronary
artery injection of polystyrene latex microspheres (70–102 mmi n
diameter) was administered 1–2 weeks apart for four to six times
by alternative catheterization of either left anterior descending
or circumﬂex arteries causing left ventricle (LV) microinfarctions.
Embolizations were discontinued when LV ejection fractions were
,35%. Dogs were maintained for a period of 1 week to ensure
that infarctions produced by the last procedure were completely
healed. Ventriculograms were performed to measure LV function
prior the ﬁrst embolization and 1 week after the last microem-
bolization. Two weeks after the last ventriculogram, dogs were
anesthetized (sodium thiopental 25 mg/kg iv followed by isoﬂurane
0.75–1.5%), the heart exposed, and tissue from the free wall of the
LV collected. The control group consisted of ﬁve age-matched
control dogs that did not undergo either the cardiac catheterization
or the multiple sequential intracoronary microembolization pro-
cedure, and were studied at the same time and were monitored
clinically and biochemically in a similar fashion to the HF group,
as previously described.
20,21
2.3 Isolation of mitochondria
Cardiac SSM and IFM were isolated from the LV using a reported
protocol,
17 with some modiﬁcations. Cardiac SSM were released
by treating the minced muscle with collagenase 2 (Worthington
Biochemical Corporation), 25 mg/g wet wt, for 10 min at 48Ci n
modiﬁed Chappel-Perry buffer (100 mM KCl, 50 mM Mops, 5 mM
MgSO4.7H2O, 1 mM EGTA, 1 mM ATP, pH 7.4 at 48C), followed by
Potter-Elvehjem homogenization. The mitochondria enriched-
supernatant (centrifugation for 10 min at  584 g), was centrifuged
at  3000 g to pellet the SSM. The remaining myoﬁbrillar pellet was
treated with a combination of trypsin (5 mg/g wet wt, for 10 min at
48C) and Polytron homogenization (10 000 r.p.m. for 2.5 s). The
activity of the protease was attenuated with an equal volume of
the modiﬁed Chappel-Perry buffer plus 0.2% defatted BSA, and
the homogenate centrifuged at  584 g for 10 min. The IFM were
pelleted by centrifugation from the supernatant at  3000 g for
10 min. Mitochondrial pellets were washed twice and ﬁnally sus-
pended in KME (100 mM KCl, 50 mM Mops, and 0.5 mM EGTA, pH
7.4). Mitochondrial protein concentration was determined by the
Lowry method using bovine serum albumin as a standard.
22
2.4 Oxidative phosphorylation
Oxygen consumption was measured with a Clark-type electrode in a
ﬁnal volume of 0.5 mL of respiration buffer (80 mM KCl, 50 mM
Mops, 1 mM EGTA, 5 mM KH2PO4, and 1 mg/mL defatted BSA, pH
7.4)
23,24 at 308C with glutamate (20 mM) without or with malate
(5 mM), pyruvate (10 mM) plus malate (5 mM), succinate (20 mM)
plus rotenone (3.75 mM), duroquinol (DHQ, 1 mM) plus rotenone,
N,N,N0,N0-tetramethyl-p-phenylenediamine (TMPD) plus ascorbate
(1:10 mM) plus rotenone, as substrates. After depletion of endogenous
substrates with 100 mM ADP (ﬁnal concentration), State 3 respiration
rate was measured in the presence of 200 mM ADP (ADP-dependent)
and State 4 respiration was recorded after ADP consumption
(ADP-limited). When mitochondria oxidize complex II, III, and IV
substrates, respiratory state 3 was recorded with 100 mMA D P .
Then sequential additions of 2 mM ADP and 200 mM of the uncoupler
dinitrophenol (DNP) were made, as described.
25 Respiratory control
ratios (RCR, as State 3 divided by State 4) reﬂect the control of
oxygen consumption by phosphorylation (‘coupling’). The ADP/O
ratios (number of ADP molecules added for each oxygen atom con-
sumed) are an index of the efﬁciency of oxidative phosphorylation.
These indexes were calculated as described by Chance and Williams.
26
2.5 Citrate synthase activity
Citrate synthase activity was measured using a diode array spectro-
photometer at 412 nm.
27
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complex activities
Samples of fresh SSM and IFM were treated with 10 mg cholate/mg
mitochondrial protein, taken to a ﬁnal volume of 1 mg/mL MSM-
EDTA buffer supplemented with 1 mL/mL mammalian protease
inhibitor cocktail. For the assay, the samples were diluted 1:10.
For cytochrome c oxidase (COX) activity, 0.1 mg fresh intact mito-
chondria were suspended in KME buffer (100 mM KCl, 50 mM MOPS,
and 0.5 mM EGTA, pH 7.4) and assayed with and without dodecyl
b-D-maltoside.
ETC enzyme activities were measured spectrophotometrically
as speciﬁc donor–acceptor oxidoreductase activities in 0.1 M phos-
phate buffer. Both donors and acceptors span speciﬁc regions of
the ETC.
23,28,29 Rotenone-sensitive NADH-cytochrome c reductase
assesses complexes I and III. NADH coenzyme Q reductase was
measured as the rotenone-sensitive oxidation of NADH with decylubi-
quinone as acceptor, and assesses only complex I. NADH ferricyanide
reductase measures NADH dehydrogenase and mitochondrial outer
membrane cytochrome b5 (rotenone-insensitive NADH-reductase).
Antimycin A-sensitive succinate-cytochrome c reductase asse-
sses complexes II and III. Complex II activity was measured as the
thenoyltriﬂuoroacetone-sensitive reduction of 2,6-dicholorophenolin-
dophenol with succinate as substrate, whereas total complex II was
measured in the same manner but with duroquinone added as a
source of exogenous coenzyme Q. Succinate dehydrogenase measures
the ﬁrst two subunits of complex II. Decylubiquinol-cytochrome c
oxidoreductase was measured as the antimycin A-sensitive reductase
to assess complex III. COX was measured as the oxidation of reduced
cytochrome c and expressed as the ﬁrst-order rate constant. Mito-
chondrial cytochrome contents (b, c1,a a 3, c) were determined
using the method of Williams.
30
2.7 Polarographic assay of cytochrome c oxidase
Frozen-thawed mitochondria were suspended in buffer containing
20 mM KH2PO4 (pH 7.4) and 0.1 mM EDTA at a concentration of
1 mg mitochondrial protein per millilitre. The activity of COX was
measured as azide-sensitive rate of oxygen consumption in the
presence of 1 mM TMPD, 10 mM sodium ascorbate in potassium
phosphate buffer at 308C using the endogenous cytochrome c
bound to the enzyme. A separate assay was performed in the
presence of 8 mM exogenous cytochrome c. Because COX activity
depends on the membrane cardiolipin content,
31,32 the activity
also was measured in the presence and absence of exogenous
soybean asolectin, a source of phospholipids including cardiolipin.
2.8 Separation of mitochondrial supramolecular
complexes by Blue Native PAGE electrophoresis
BN-PAGE was performed using the method of Schagger and Wittig.
33
Mitochondrial proteins were extracted with digitonin (detergent:
protein ratio of 6:1 g/g), combined with Coomasie blue G-250 dye
(detergent/dye ratio of 8:1 g/g), and separated on 3–13% acryl-
amide–bisacrylamide gradient gels. Densitometric evaluation of
the gels was carried out using Image J from the National Institutes
of Health and Multi Gauge V3.0 from Fujiﬁlm Life Science.
2.9 Statistical analysis
The results were analysed using the student’s two-tailed t-test.
Data are reported as mean+SEM. To be considered signiﬁcant,
P-value had to be less than 0.05.
3. Results
3.1 Haemodynamic ﬁndings
There was a progressive worsening in LV function from 1 to
13 weeks following the last microembolization, as evidenced
by increases in the LV end-systolic volume (from 42+1
to 47+1 mL) and end-diastolic volume (from 64+2t o
67+2 mL), and a fall in ejection fraction (from 34+1t o
28+1) (P , 0.05 for all parameters).
3.2 Mitochondrial marker enzyme activities
Mitochondrial marker enzyme activities (citrate synthase
and succinate dehydrogenase) in fresh heart homogenate,
as indicators of mitochondrial content, were not changed
in HF. The yields of heart SSM and IFM isolated from HF
appear to be lower than those isolated from the control, but
the alterations are not statistically signiﬁcant (P-values are
0.227 for SSM and 0.065 for IFM). Also, no differences were
found in the speciﬁc activity of mitochondrial marker
enzymesinbothSSMandIFMfromcontrolandHFdogs(Table 1).
3.3 Oxidative phosphorylation
Glutamate oxidation (Table 2) reﬂects mitochondrial gluta-
mate uptake, glutamate dehydrogenase, the activity of
the ETC, and the phosphorylation process. Both SSM and
IFM isolated from HF have state 3 respiratory rates that
are approximately 50% of those from control hearts.
The RCRs (state 3/state 4) in heart SSM and IFM from
control dogs are 34+7 and 39+14, respectively, with glu-
tamate as substrate. These values demonstrate that both
heart SSM and IFM isolated from control dogs are highly
coupled. These RCRs for dog heart mitochondria are higher
than those reported by our group for rat heart mitochondria
oxidizing glutamate,
17 but are similar to those reported
(from 33+7.5 to 39.6+1.6) in the literature for the com-
bined population (SSM þ IFM) of mitochondria isolated from
chicken heart.
34 The RCR values were slightly decreased in
HF due exclusively to the decline in state 3 respiratory
rates, but the values did not reach statistical signiﬁcance.
State 4 respiratory rates were 15+5 nA O/min/mg in
control dog heart SSM and 20+6 nA O/min/mg in
control dog heart IFM oxidizing glutamate, and these
values did not change in mitochondria isolated from HF
Table 1 Speciﬁc activities of mitochondrial marker enzymes in
heart homogenate and isolated subsarcolemmal (SSM) and
interﬁbrillar (IFM) mitochondria
Control Heart failure
Heart homogenate
Citrate synthase (U/g wet wt) 81.0+5.0 84.0+5.4
Succinate dehydrogenase,
(U/g wet wt)
5.0+0.3 5.0+0.8
Isolated mitochondria
Citrate synthase, (mU/mg
protein)
SSM 1975+139 1902+297
IFM 2136+166 2088+258
Succinate dehydrogenase,
(mU/mg protein)
SSM 261+40 251+21
IFM 268+45 261+34
Mitochondrial yield (mg/g wet wt)
SSM 10.5+0.7 7.6+1.8
IFM 10.6+1.3 5.4+1.2
n ¼ 5 for control and n ¼ 5 for heart failure. Mean+SEM.
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IFM). These state 4 respiratory rates are similar to those
measured in rat heart mitochondria.
17 Thus, the notable
RCRs reﬂect the high state 3 rates of oxidation rather than
a decrease in state 4 in dog heart mitochondria.
Also, the ADP/O ratios were not changed in either SSM or
IFM isolated from HF compared with the control hearts.
These data revealed that, despite the severe decline in
state 3, the coupling abilities of both populations of heart
mitochondria are preserved in HF. The decreased respiratory
rates were not relieved by the addition of either saturating
concentration of ADP or by the uncoupler DNP, showing that
the mitochondrial defect does not reside in the phosphoryl-
ation apparatus.
In order to dissect the oxidative phosphorylation into
functional components, we also employed substrates that
use different mitochondrial transport systems and dehydro-
genases, the tricarboxylic acid cycle, and that donate their
reducing equivalents to selective sites in the ETC.
Figure 1 shows the respiratory properties of heart SSM
and IFM in the presence of complex I, II, III, and IV substrates.
The combination of glutamate þ malate investigates the
aspartate shuttle, whereas pyruvate þ malate assesses the
monocarboxylate and dicarboxylate transporters and pyru-
vate dehydrogenase. Both substrate combinations produce
NADH, which donates electrons to complex I. Heart SSM
and IFM isolated from HF had approximately 45% state 3
respiratory rates compared with control mitochondria, irre-
spective of complex I substrates processing. CPT-I-dependent
and -independent lipid substrates (complex I and complex III
electron donors, via electron transfer ﬂavoprotein-ETF and
ETF-Q reductase) also were oxidized at signiﬁcantly lower
rates (see Supplementary material online, Figure S1).
SuccinatedonateselectronstoFADincomplexII,andyields
signiﬁcantly lower respiratory state 3 rates in both
cardiac SSM and IFM isolated from HF compared with the
control. The respiratory state 3 rates with duroquinol, as a
complex III electron donor, were signiﬁcantly lower in both
SSM and IFM isolated from HF compared with the control
hearts. State 3 respiratory rates with the cytochrome c elec-
tron donor TMPD-ascorbate also were signiﬁcantly decreased
by HF in both SSM and IFM.
A deﬁnitive localization of the defect in the oxidative phos-
phorylation process is provided by measuring the uncoupled
Figure 1 State 3 respiratory rates of heart subsarcolemmal mitochondria (A)
and interﬁbrillar mitochondria (B). State 3 was induced by 200 mM ADP when
mitochondria oxidize complex I substrates (GlutamateþMalate and
PyruvateþMalate), and 100 mM ADP when mitochondria oxidize complexes
II (Succinateþrotenone), III (Duroquinol, DHQþrotenone), and IV via cyto-
chrome c (TMPD ascorbateþrotenone). M, malate. *P , 0.05 control (n ¼ 5)
vs. heart failure (n ¼ 5). Mean+SEM.
Table 2 Oxidative properties of subsarcolemmal mitochondria
(SSM) and interﬁbrillar mitochondria (IFM) isolated from heart of
control and heart failure dogs
Control Heart failure
SSM
State 3 514+41 214+33*
State 4 15+51 5 +3
RCR 34+71 8 +4
ADP/O 2.77+0.09 2.69+0.02
Maximal ADP 619+41 191+22*
DNP 608+32 191+38*
IFM
State 3 472+26 223+12*
State 4 20+61 6 +4
RCR 39+14 17+3
ADP/O 2.78+0.15 2.85+0.15
Maximal ADP 529+16 221+17*
DNP 535+10 206+19*
Glutamate as substrate. RCR, respiratory control ratio (state 3/state
4); ADP/O, ADP to atomic oxygen phosphorylation ratio; Maximal ADP,
state 3 with saturating 2 mM ADP; DNP, dinitrophenol. Respiratory rates
are expressed as nA O/min/mg mitochondrial protein. n ¼ 5 for control
and n ¼ 5 for HF. Mean+SEM.
*P , 0.05.
Figure 2 Uncoupled (200 mM dinitrophenol) respiratory rates of heart sub-
sarcolemmal mitochondria (A) and interﬁbrillar mitochondria (B). Substrates
that donate reducing equivalents to complexes I (Glutamate), II (Succinateþ
rotenone), III (Duroquinol, DHQþrotenone), and IV via cytochrome c (TMPD
ascorbateþrotenone). *P , 0.05 control (n ¼ 5) vs. heart failure (n ¼ 5).
Mean+SEM.
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upon collapsing of mitochondrial potential with the
protonophore DNP with all substrates tested showed that
neither the amount nor the activity of the components of
the phosphorylation apparatus (adenine nucleotide trans-
locase-ANT isoforms, phosphate transporter, ATP synthase)
werethesitesofthedefectinbothcardiacSSMandIFMisolated
from HF (Figure 2). Moreover, respiratory state 3 rates were
not improved by the addition of saturating concentrations of
ADP (see Supplementary material online, Figure S2)s h o w i n g
that the defect was localized in mitochondrial structures
situated upstream from ANT in the respiratory chain.
3.4 The activity of mitochondrial electron
transport chain complexes
The individual activities of the mitochondrial ETC enzymes
were not affected (Figure 3). In addition, COX activity,
measured under isosmotic conditions to assess outer mem-
brane leakage, was 3.2+1 and 2.5+0.5% of the total
activity in control SSM and IFM, respectively, and was not
modiﬁed in HF. These data show that the outer membrane
is essentially intact and is preserved in HF in both heart
mitochondrial populations.
Also,whenmeasuredinfreshheartmusclehomogenate,the
combined activities of complexes I/III (rotenone-sensitive
NADH cytochrome c reductase, NCR) and complexes II/III
(antimycin-sensitive succinate cytochrome c reductase, SCR),
as well as the activity of decylubiquinol-cytochrome c
oxidoreductase (complex III) and COX (complex IV) were
unchanged, consistent with the activities of these enzymes in
isolated mitochondria (Supplementary material online,
Figure S3).
3.5 Polarographic investigation of cytochrome c
oxidase
The normal activity observed with the spectrophotometric
assay performed in the presence of exogenously added cyto-
chrome c assesses predominantly the activity of the
low-afﬁnity high-turnover binding site of cytochrome c to
COX (regulatory site).
35 The polarographic investigation of
COX in the absence of exogenously added cytochrome c
measures the velocity of oxygen consumption under con-
ditions whereby TMPD-ascorbate maintains the cytochrome
cb o u n dt oC O Xt ot h eh i g ha f ﬁ n i t y –low turnover site
(HA–LT, catalytic site) in the reduced state. COX activity
measured polarographically was not altered by HF in both
SSM and IFM in the absence of exogenously added
cytochrome c, and was increased to the same extent in
both types of control and HF heart mitochondria by the
addition of exogenous cytochrome c (Figure 4). These
results show that neither the individual COX activity nor
the reducible (functional) cytochrome bound to COX to the
HA–LT site are altered in HF. The effect of asolectin (as a
source of exogenous phospholipids) on the increase in COX
activity was similar in mitochondria isolated from both
control and HF dogs (Figure 4).
Figure 3 The activity of electron transport chain enzymes in isolated heart subsarcolemmal mitochondria (SSM) and interﬁbrillar mitochondria (IFM). The
enzyme activity was measured in detergent-solubilized, freshly isolated SSM and IFM from control (n ¼ 5) and heart failure (n ¼ 5) dogs, and expressed as
nmol/min/mg mitochondrial protein or as the ﬁrst-order rate constant (k ¼ 1/min/mg mitochondrial protein) for complex IV. NCR, rotenone sensitive NADH-
Cytochrome c Reductase; C I, complex I; NFR, NADH-Ferricyanide Reductase; SCR, antimycin A-sensitive Succinate-Cytochrome c Reductase. C II, TTFA-sensitive
complex II; C IIþQ, TTFA-sensitive Complex II with exogenous coenzyme Q analogue; C III, complex III; C IV, complex IV. Mean+SEM.
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The amount of cytochrome aa3 reducible haem, as the
main catalytic subunit of COX, as well as the amount of
the reducible haem in cytochromes b and c was unchanged
in both SSM and IFM isolated from HF. The amount of cyto-
chrome c1, contained in complex III, was signiﬁcantly
increased in IFM isolated from HF compared with the
control (Figure 5).
3.7 Supramolecular complex assemblies and
individual electron transport chain complexes
The results presented in Figures 6 and 7 provide data
showing that HF causes a decrease in the amount of
the major mitochondrial supercomplex (respirasome I/III2/
IV) in both heart SSM and IFM. One-dimensional BN-PAGE
separation of mitochondrial supercomplexes extracted
with digitonin is shown in Figures 6A and 7A. Since the
amount of complex V is not changed (Figures 6B and 7B)
and complex V is not a component of this supercom-
plex,
33,36,37 the results are further expressed as the inten-
sity of the supercomplex bands normalized to the intensity
of complex V band. Figures 6C and 7C revealed a lower
amount of the supercomplex I/III2/IV (described by Schag-
ger
33,36,37) in both types of heart mitochondria in HF. In con-
trast, the amounts of free complexes I and III were increased
in HF in SSM with free complex IV unchanged. Also, free
complexes I, III, and IV migrate at a similar molecular
weight in both control and HF, indicating that they remain
stable when not part of the supercomplex and that they
have subunit integrity (see Supplementary material online,
Figure S4).
4. Discussion
This study documents that there is a severe decrease in
oxidative phosphorylation of both populations of heart mito-
chondria (SSM and IFM) isolated from moderate severity
HF because of a decrease in the content of a major ETC
supercomplex (respirasome). The content of mitochondria
in the myocardium was unchanged in HF. Mitochondria
were intact with little or no outer membrane leakiness.
Heart mitochondria showed a dramatic decrease in the
ADP-stimulated respiration that was not relieved by an
uncoupler. RCR values are unchanged, indicating that
mitochondria are well-coupled. Also, the ADP/O ratio was
normal, indicating that HF does not affect the efﬁciency of
phosphorylation. No change in the individual activity of the
ETC complexes was found in HF. Therefore, the mitochondrial
defect resides in the assembly and function of the mitochon-
drial respirasome rather than in individual complexes.
The functional defect can only be uncovered by a compre-
hensive evaluation of mitochondria. Our approach involves
the measurement of oxidative phosphorylation, complemen-
ted with ETC complex activities, mobile electron carriers,
and coupled with the analysis of the organization of the oxi-
dative phosphorylation complexes into supercomplexes.
Oxidative phosphorylation, performed on freshly isolated
mitochondria with a comprehensive number of substrates,
assesses the integrated function of membrane transport,
dehydrogenase activity, and electron transport coupled to
ATP synthesis.
25 The lack of improvement of oxidative phos-
phorylation rates by collapsing the mitochondrial membrane
potential with an uncoupler shows that the defect is not
localized in any structure of the phosphorylation system
(ANT, ATP synthase, phosphate transporter), but rather
in electron transport. These data extend previous studies
Figure 4 The activity of cytochrome c oxidase in heart subsarcolemmal
mitochondria (A) and interﬁbrillar mitochondria (B) determined polarographi-
cally. C, cytochrome c. A, asolectin. Mean+SEM.
Figure 5 Cytochrome content in heart subsarcolemmal mitochondria (A) and interﬁbrillar mitochondria (B). *P , 0.05 control vs. HF. Mean+SEM.
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9,16 However, a great variability of mito-
chondrial ETC defects is described in acquired cardiomyopa-
thies
4,6,38–40 without a consistent trend for depressed
activity or expression. In this study, the dramatic drop in oxi-
dation of all substrates was not supported by defects in the
individual activity of any ETC complex. COX activity, total
and COX-bound reducible (functional) form of cytochrome
c, and both catalytic and regulatory COX cytochrome c
binding sites also are normal in HF.
Complexes of the mitochondrial oxidative phosphory-
lation system assemble into supramolecular structures called
respiratory supercomplexes, as revealed by (i) kinetic
studies using ﬂux control analysis,
41 (ii) single particle elec-
tron microscopy,
42,43 (iii) studies that show the instability of
human respirasome in patients with genetic mitochondrial
disorders,
36 (iv) studies on the stability of oxidative phos-
phorylation complexes with induced point mutations in a
speciﬁc complex,
44 and (v) separation by BN-PAGE pro-
cedures, which yield assemblies of oxidative phosphoryla-
tion enzymes rather than individual complexes. The
supramolecular organization of the oxidative phosphoryla-
tion system is strongly conserved from fungal,
45 plant,
46
beef,
37,42 to human
37 mitochondria. Supercomplexes
consisting of complexes I/dimer III/one to four copies of IV
(I/III2/IV1-4)w e r ep r o p o s e dt ob ec a l l e dr e s p i r a s o m e s ,
36
because they autonomously can carry out respiration in
the presence of ubiquinone and cytochrome c. In yeast
complex IV assemblies with complex III and does not occur
signiﬁcantly in free form.
37 The I/III2/IV1–4 supercomplexes
represent the major forms of respirasomes in mammalian
mitochondria. Also, in mammalian mitochondria, almost all
complex I is assembled into respirasomes.
37 Moreover, we
have found complex I only in respirasomes, but not in the
free monomeric form in normal human skeletal muscle
(unpublished observation).
We report that the amount of the supramolecular com-
plex I/III2/IV is decreased in HF in both heart mitochondrial
populations. In contrast, the amounts of free monomeric
complexes I and III are signiﬁcantly increased in heart SSM
isolated from HF. However, the total amounts of complexes
Figure 6 Separation of supramolecular assemblies of mitochondrial oxidative phosphorylation complexes by 1D BN-PAGE in subsarcolemmal mitochondria (SSM)
of control and heart failure hearts. (A) Dog heart SSM solubilized with digitonin using a 6:1 digitonin/protein ratio (g/g) and separated by one-dimensional
BN-PAGE. C I, C II, C III, C IV, and C V (right) indicate mitochondrial complexes I–V and correspond to bands 1–5 (left). Bands 6–9 (left) indicate supermolecular
complexes. Band 8 indicates supercomplex CI-CIII2-CIV. (B) Complex V (C V). (C) The density of the band corresponding to supercomplex CI-CIII2-CIV (arrows) and
of the bands corresponding to complexes I, III, and IV were normalized to the density of complex V band. *P , 0.05 control vs. HF. Mean+SEM. One-dimensional
BN-PAGE, one-dimensional blue native PAGE.
M.G. Rosca et al. 36I and III extracted by dodecyl b-D-maltoside are unchanged.
Therefore, there is a decreased incorporation of complexes I
and III within I/III2/IV respirasome in SSM.
By facilitating the activity of catalytic subunits, super-
complexes represent regulatory units of mitochondrial oxi-
dative phosphorylation.
47 We propose that the decrease in
supramolecular organization of the oxidative phosphoryl-
ation leading to loss of the functional advantage of this
respirasome organization, such as channelling of electrons
and substrates,
48 causes the severe decrease in the integra-
tive mitochondrial function. Our proposal is supported
by studies on supramolecular assembly of mitochondrial
oxidative phosphorylation in humans with mitochondrial dis-
orders. For example, humans harbouring a genetic defect
in cardiolipin remodelling (Barth syndrome) have unstable
oxidative phosphorylation supercomplexes, associated with
mitochondrial morphological abnormalities,
49 decreased
mitochondrial potential,
50 and decreased activity of the
ETC complexes.
51 Also, after screening a large number of
mitochondrial specimens from muscle biopsies of patients
with mitochondrial disorders, Schagger
36 reported deﬁci-
encies in the assembly of complexes I and IV.
The 50% decrease in mitochondrial oxidative phosphoryl-
ation with normal individual activity of the ETC complexes
was accompanied by an approximately 33 and 50% decrease
in the amount of respirasome in SSM and IFM, respectively.
We propose that the severe decrease in oxidative phosphoryl-
ationisdependentupontheformationoffunctionalsupercom-
plexes. This idea is supported by recent studies in hybrid cells
harbouring mtDNA mutations within COX I and cytochrome b
genes that experience both a collapse in oxidative phosphoryl-
ation and complete absence of fully assembled functional
supercomplexes. The decrease in the proportion of these
mtDNA mutations leads to increase in the complex III- and
IV-containing supercomplexes rather than their free form,
and a complete recovery of oxidative phosphorylation. The
authors concluded that the amount and activity of individual
complexes are not rate-limiting for mitochondrial respiration,
and it is the ability of the ETC to organize in supercomplexes
that sets the threshold for the phenotypic expression of the
mtDNA defects.
52 The amount of free complexes I and III was
increased in SSM isolated from HF hearts. In IFM, there is a
trend toward higher free complex III amount. These free
complexes might represent a functional reserve and be in a
dynamic equilibrium with those organized in supercomplexes,
assuggested bythe semi-solid-statemodel of the organization
of oxidative phosphorylation.
52
The present study demonstrates that both populations of
heart mitochondria are equally affected during this model
of microembolism-induced HF of moderate severity. This
Figure 7 Separation of supramolecular assemblies of mitochondrial oxidative phosphorylation complexes by one-dimensional BN-PAGE in interﬁbrillar mitochon-
dria (IFM) of control and heart failure hearts. (A) Dog heart IFM solubilized with digitonin using a 6:1 digitonin/protein ratio (g/g) and separated by 1D BN-PAGE. C
I, C II, C III, C IV, and C V (right) indicate mitochondrial complexes I–V and correspond to bands 1–5 (left). Bands 6–9 (left) indicate supermolecular complexes.
Band 8 (arrows) indicates supercomplex CI-CIII2-CIV. (B) Complex V (C V). (C) The density of the band corresponding to supercomplex CI-CIII2-CIV (arrows) and of
the bands corresponding to complexes I, III, and IV were normalized to the density of complex V band. *P , 0.05 control vs. HF. #P ¼ 0.07 control vs. HF. Mean+
SEM. One-dimensional BN-PAGE, one-dimensional blue native PAGE.
Mitochondrial integrative function in heart failure 37conclusion is supported by both the oxidative phosphoryl-
ation data and the amount of supercomplexes.
In summary, the current study documents a dramatic
decrease in oxidative phosphorylation of heart mitochondria
isolated from moderately severe HF. The defect is caused by
a decrease in the content of the major mitochondrial supra-
molecular complex (respirasome). Our data reveal a new
mitochondrial disorder in HF that ﬁts in the category of
mitochondrial cytopathies.
Supplementary material
Supplementary material is available at Cardiovascular
Research online.
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